AKT1 and neoplasm: In tumor-promoting settings, it can activate oncogenic signaling (e.g., Wnt/β-catenin, ILK/AKT/mTOR, MAPK), induce inflammation/oxidative stress, and enhance proliferation, angiogenesis and metastasis [174–177].